Liberty Vision presents LV Yttrium-90 Discs and iWand® applicators for the treatment of ocular tumors and benign growths.
Yttrium-90 Episcleral Brachytherapy Source
- High-purity beta radiation disc source, single use
- Configurable activity for each order
- Quick treatment, dwell time of minutes, not days
- Environmentally friendly, decays in weeks, not decades
Manual Radionuclide Applicator System
- Facilitates accurate LV Y-90 Disc positioning
- Minimally invasive, extraocular, single use
- Anterior with integrated transparent shielding features
- Posterior with integrated positioning light features
Our mission is to bring advanced technology and methods to vision care, resulting in a better quality of life for patients and greater therapeutic value for physicians.
Innovations
Liberty Vision’s beta radiation discs and applicators are designed for ocular use. Our CEO and Chief Medical Officer, Paul T. Finger, MD, has spent decades researching and perfecting ophthalmic radiation devices through clinical research in collaboration with world-renowned medical physics and radiation experts. This knowledge has been used to perfect Liberty Vision’s Y-90 Disc radiation sources and its iWand® series of hand-held applicators.
Safe and Effective Treatments
Liberty Vision recognized the unmet potential to treat many eye diseases with radiation. This drove Liberty Vision to create and patent delivery systems that make application of brachytherapy straightforward, accurate, and easy to use.
Liberty Vision’s mission is to create the tools eye doctors need to deliver safe and effective radiation to maximize their patient outcomes.
Articles
Liberty Vision’s Y-90 Radiation System is not just for eye cancer
Imagine that there was an ophthalmic tool that could quickly treat a wide range of eye conditions by custom-tuning the treatment dose to achieve the effect you wanted. Liberty Vision has brought just such a tool to ophthalmic practice. It incorporates their...
LV Y-90 Use at Duke Eye Center – Advancing Ocular Oncology Through the Power of Partnership
In the 2024 copy of VISION magazine, Duke Eye Center features the Liberty Vision Y-90 Disc procedure that the center has recently started performing. Under the guidance of Dr. Miguel Materin, MD, Division Chief of Duke's newly formed Division of Ocular Oncology, Duke...
Publication: First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance
Liberty Vision is pleased to announce the world's first publication on LV Y-90 Disc brachytherapy! This new technology was initially employed to treat patients with iris, and iridociliary melanomas as well as ocular surface...